ArticleSarcoma2018

The Value of MRI in Distinguishing Subtypes of Lipomatous Extremity Tumors Needs Reassessment in the Era of MDM2 and CDK4 Testing.

Sean Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.